Table 3.
Changes in outcome measures with Active+me (mean; 95% Confidence Intervals)
| Variable | Baseline | Follow-up | P-Value | Effect Size |
|---|---|---|---|---|
| PAM Scores✝ | 65.5 (51.0 to 100.0) | 70.2 (40.7 to 100.0) | 0.039* | 0.101 |
| Patients with PAM Level 1 (%) | 0 (0.0) | 2 (4.3) | 0.107 | – |
| Patients with PAM Level 2 (%) | 6 (13.0) | 4 (8.7) | ||
| Patients with PAM Level 3 (%) | 23 (50.0) | 20 (43.5) | ||
| Patients with PAM Level 4 (%) | 14 (30.4) | 17 (37.9) | ||
| Daily Steps | 8312 (7314 to 9571) | 8484 (7020 to 9814) | 0.734 | 0.045 |
| Daily Physical Activity Duration (Minutes) | 94.7 (81.1 to 109.8) | 101.7 (82.0 to 119.0) | 0.296 | 0.100 |
| Body Mass Index (kg.m2) | 27.9 (26.4 to 29.5) | 27.7 (26.1 to 29.3) | 0.126 | 0.067 |
| Resting Systolic Blood Pressure (mmHg) | 125 (120 to 130) | 119 (115 to 122) | 0.023* | 0.445 |
| Resting Diastolic Blood Pressure (mmHg) | 75 (71 to 79) | 72 (69 to 75) | 0.184 | 0.234 |
| Resting Heart Rate✝ (bpm) | 62 (44 to 93) | 64 (46 to 87) | 0.149 | 0.053 |
| Waist circumference (cm) | 92.8 (82.6 to 102.9) | 85.3 (79.1 to 96.2) | 0.026* | 0.506 |
| PHQ Questionnaire✝ | 4.0 (0.0 to 23.0) | 2.0 (0.0 to 19.0) | 0.619 | 0.016 |
| GAD Questionnaire✝ | 3.0 (0.0 to 21.0) | 1.5 (0.0 to 14.0) | 0.693 | 0.010 |
| WSA Scale Score✝ | 4.0 (0.0 to 24.0) | 1.0 (0.0 to 23.0) | 0.906 | 0.001 |
| TAM2 Score✝ (MET-minutes per week) | 1557.5 (245.0 to 5355.0) | 3363.2 (105.0 to 12,360.0) | < 0.001* | 0.419 |
PAM Patient Activation Measure, PHQ Patient Health Questionnaire, General Anxiety Disorder, WSA Work and Social Adjustment, TAM2 Total Activity Measurement, MET Metabolic Equivalents
✝ = Non-Parametric Analysis; * significant difference